iX Biopharma (SGX:42C) narrowed its loss during the fiscal third quarter ended March 31 to SG$916,000 from SG$2.2 million a year earlier, according to a Friday filing with the Singapore Exchange.
Shares of the pharmaceutical and nutraceutical company were down over 1% in late-afternoon trading.
Loss per share stood at SG$0.0009 compared with SG$0.0025 in the year-ago period.
Revenue declined 13% year over year to SG$1.6 million from SG$1.8 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments